Newsfeeds - Spark Newswire

5 minute read

Vidprevtyn Beta Covid-19 Booster Vaccine, Developed By Sanofi And GSK, Approved For Use In Great Britain

Today, 8:03 AM

https://www.gsk.com/en-gb/media/press-releases/vidprevtyn-beta-covid-19-booster-vaccine-approved-for-use-in-great-britain/ SARS-CoV-2 spike protein (B.1.351 strain) vaccine is the first and only protein-based variant

GSK

1 minute read

Comparing With Pfizer’s Vaccine, Icosavax RSV Candidate ‘Could Establish Differentiation,’ Analyst Says

By Vandana Singh

Today, 8:03 AM

Icosavax Inc (NASDAQ:ICVX) provided a six-month immunogenicity update from its Phase 1/1b trial of IVX-121 against Respiratory Syncytial Virus (RSV), demonstrating…

GSK

1 minute read

Options Trader Betting On GSK Stock Rising Heading Into 2023

By Lisa Levin

Today, 8:03 AM

Options traders are making big bets on the upside for healthcare, particularly in shares of GSK plc (NYSE: GSK).

GSK

1 minute read

Wave Life Sciences Shares Move Higher On Therapeutic Pact With GSK Targeting Genetic Disorders

By Vandana Singh

Today, 8:03 AM

Wave Life Sciences Ltd (NASDAQ:WVE) and GSK plc (NYSE:GSK) have announced a strategic collaboration to advance oligonucleotide therapeutics, including Wave’s preclinical RNA editing…

GSK

1 minute read

Relief To Pfizer, Sanofi As US Dismisses Several Lawsuits Associated With Zantac

By Vandana Singh

Today, 8:03 AM

U.S. District Judge Robin Rosenberg in Florida has dismissed about 50,000 claims associated with GSK Plc (NYSE:GSK), Pfizer Inc (NYSE:PFE), Sanofi SA (NASDAQ:SNY), and Boehringer Ingelheim, claiming…

GSK

1 minute read

Why GSK Plc And Sanofi SA Stock Are Shooting Higher

By Henry Khederian

Today, 8:03 AM

Shares of GSK plc (NYSE: GSK) and Sanofi SA (NASDAQ: SNY) are trading higher going into the close of Tuesday's session after the companies reportedly won a Zantac product liability lawsuit.

GSK

2 minute read

GSK’s Debt Overview

By Benzinga Insights

Today, 8:03 AM

Over the past three months, shares of GSK Inc. (NYSE:GSK) moved higher by 19.05%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.

GSK

1 minute read

GSK, Pfizer, Sanofi, Boehringer Ingelheim Defeat Thousands Of U.S. Lawsuits Over Zantac Cancer Claims; Cases In Federal Court Will End While Others Continue In State Courts

By Benzinga Newsdesk

Today, 8:03 AM

- Court Order

GSK

1 minute read

Hearing GlaxoSmithKline And Sanofi Wins In A Zantac Product Liability Lawsuit; The Companies Were Granted Summary Judgement By The Court; Shares Move Higher

By Benzinga Newsdesk

Today, 8:03 AM

"As a result, if the plaintiff does not have this evidence, there is no genuine dispute of material fact, and the defendant is entitled to judgement as a matter of law," according to the judge's

GSK

2 minute read

News

GSK Announced Jemperli RUBY Phase III Trial Met Primary Endpoint in Planned Interim Analysis in Patients With Primary Advanced or Recurrent Endometrial Cancer

By Charles Gross

Today, 8:03 AM

GSK plc (LSE/NYSE: GSK) today announced positive headline results from the planned interim analysis of Part 1 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial investigating Jemperli (dostarlimab) plus standard-of-care chemotherapy (carboplatin-paclitaxel) followed by Jemperli compared to chemotherapy plus placebo followed by placebo in adult patients with primary advanced or recurrent endometria

GSK